Long-term efficacy and safety of certolizumab pegol in Japanese rheumatoid arthritis patients with an inadequate response to methotrexate: 52-week results from an open-label extension of the J-RAPID study

Objectives. To evaluate the long-term efficacy and safety of certolizumab pegol (CZP) plus methotrexate treatment and to assess the efficacy of two CZP maintenance dosing schedules in Japanese rheumatoid arthritis (RA) patients with an inadequate response to methotrexate. Methods. J-RAPID double-bli...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yoshiya, Yamamoto, Kazuhiko, Takeuchi, Tsutomu, Yamanaka, Hisashi, Ishiguro, Naoki, Eguchi, Katsumi, Watanabe, Akira, Origasa, Hideki, Shoji, Toshiharu, Miyasaka, Nobuyuki, Koike, Takao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2014
Materias:
Original Articles: Rheumatoid Arthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819587/
https://www.ncbi.nlm.nih.gov/pubmed/24593170
http://dx.doi.org/10.3109/14397595.2014.881709

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4819587/
https://www.ncbi.nlm.nih.gov/pubmed/24593170
http://dx.doi.org/10.3109/14397595.2014.881709

Ejemplares similares